These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 36346820)

  • 1. Hypomagnesemia and Cardiovascular Risk in Type 2 Diabetes.
    Oost LJ; Tack CJ; de Baaij JHF
    Endocr Rev; 2023 May; 44(3):357-378. PubMed ID: 36346820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes.
    Handelsman Y
    Adv Ther; 2019 Oct; 36(10):2567-2586. PubMed ID: 31444707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between hypomagnesemia, metformin therapy and cardiovascular disease complicating type 2 diabetes: the Fremantle Diabetes Study.
    Peters KE; Chubb SA; Davis WA; Davis TM
    PLoS One; 2013; 8(9):e74355. PubMed ID: 24019966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-diabetic treatment, insulin resistance and cardiovascular disease in patients with type 2 diabetes].
    Hemmingsen B; Lund SS; Vaag A
    Ugeskr Laeger; 2009 May; 171(19):1598-602. PubMed ID: 19419642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of cardiovascular disease in patients with diabetes.
    Hudspeth B
    Am J Manag Care; 2018 Aug; 24(13 Suppl):S268-S272. PubMed ID: 30160393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type-2 diabetes mellitus and cardiovascular disease.
    Henning RJ
    Future Cardiol; 2018 Nov; 14(6):491-509. PubMed ID: 30409037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease.
    Andreadi A; Muscoli S; Tajmir R; Meloni M; Muscoli C; Ilari S; Mollace V; Della Morte D; Bellia A; Di Daniele N; Tesauro M; Lauro D
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Magnesium Status, Dietary Magnesium Intake, and Metabolic Control in Patients with Type 2 Diabetes Mellitus.
    Ozcaliskan Ilkay H; Sahin H; Tanriverdi F; Samur G
    J Am Coll Nutr; 2019 Jan; 38(1):31-39. PubMed ID: 30160617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Magnesium Is Inversely Associated With Heart Failure, Atrial Fibrillation, and Microvascular Complications in Type 2 Diabetes.
    Oost LJ; van der Heijden AAWA; Vermeulen EA; Bos C; Elders PJM; Slieker RC; Kurstjens S; van Berkel M; Hoenderop JGJ; Tack CJ; Beulens JWJ; de Baaij JHF
    Diabetes Care; 2021 Aug; 44(8):1757-1765. PubMed ID: 34385344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of New-Onset Atrial Fibrillation With Risks of Cardiovascular Disease, Chronic Kidney Disease, and Mortality Among Patients With Type 2 Diabetes.
    Geng T; Wang Y; Lu Q; Zhang YB; Chen JX; Zhou YF; Wan Z; Guo K; Yang K; Liu L; Liu G; Pan A
    Diabetes Care; 2022 Oct; 45(10):2422-2429. PubMed ID: 35984477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding type 2 diabetes mellitus and associated cardiovascular disease: linked by insulin resistance.
    Tennyson GE
    Am J Manag Care; 2002 Oct; 8(16 Suppl):S450-9. PubMed ID: 12408408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of cardiovascular risk factors with pioglitazone combination therapies in type 2 diabetes: an observational cohort study.
    Rodríguez A; Reviriego J; Karamanos V; del Cañizo FJ; Vlachogiannis N; Drossinos V;
    Cardiovasc Diabetol; 2011 Feb; 10():18. PubMed ID: 21314919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Type 2 diabetes, cardiovascular risk, and the link to insulin resistance.
    Stolar MW; Chilton RJ
    Clin Ther; 2003; 25 Suppl B():B4-31. PubMed ID: 14553864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in prevalence of cardiovascular risk factors from 2002 to 2012 among youth early in the course of type 1 and type 2 diabetes. The SEARCH for Diabetes in Youth Study.
    Kim G; Divers J; Fino NF; Dabelea D; Lawrence JM; Reynolds K; Bell RA; Mayer-Davis E; Crume T; Pettitt DJ; Pihoker C; Liu L
    Pediatr Diabetes; 2019 Sep; 20(6):693-701. PubMed ID: 30903717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis.
    Verma H; Garg R
    J Hum Nutr Diet; 2017 Oct; 30(5):621-633. PubMed ID: 28150351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral hypoglycaemic agents, insulin resistance and cardiovascular disease in patients with type 2 diabetes.
    Hemmingsen B; Lund SS; Wetterslev J; Vaag A
    Eur J Endocrinol; 2009 Jul; 161(1):1-9. PubMed ID: 19369429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between hypomagnesemia and poor glycaemic control in type 1 diabetes is limited to insulin resistant individuals.
    Oost LJ; van Heck JIP; Tack CJ; de Baaij JHF
    Sci Rep; 2022 Apr; 12(1):6433. PubMed ID: 35440685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Demographic and Lifestyle Variables on Plasma Magnesium Concentrations and Their Associations with Cardiovascular Risk Factors in a Mediterranean Population.
    Barragán R; Llopis J; Portolés O; Sorlí JV; Coltell O; Rivas-García L; Asensio EM; Ortega-Azorín C; Corella D; Sánchez-González C
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32276338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimated Life-Years Gained Free of New or Recurrent Major Cardiovascular Events With the Addition of Semaglutide to Standard of Care in People With Type 2 Diabetes and High Cardiovascular Risk.
    Westerink J; Matthiessen KS; Nuhoho S; Fainberg U; Lyng Wolden M; Østergaard HB; Visseren F; Sattar N
    Diabetes Care; 2022 May; 45(5):1211-1218. PubMed ID: 35263432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoglycemia, diabetes, and cardiovascular disease.
    Snell-Bergeon JK; Wadwa RP
    Diabetes Technol Ther; 2012 Jun; 14 Suppl 1(Suppl 1):S51-8. PubMed ID: 22650225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.